All Stories

  1. 3D RNA nanocage for encapsulation and shielding of hydrophobic biomolecules to improve the in vivo biodistribution
  2. Construction of RNA nanotubes
  3. Photo-controlled release of paclitaxel and model drugs from RNA pyramids
  4. RNA versatility, flexibility, and thermostability for practice in RNA nanotechnology and biomedical applications
  5. An Arginine Finger Regulates the Sequential Action of Asymmetrical Hexameric ATPase in the Double-Stranded DNA Translocation Motor
  6. Precise spatial control of cavitation erosion in a vessel phantom by using an ultrasonic standing wave
  7. Development of Potent Antiviral Drugs Inspired by Viral Hexameric DNA-Packaging Motors with Revolving Mechanism
  8. Controllable self-assembly of RNA dendrimers
  9. Biological Nanomotors with a Revolution, Linear, or Rotation Motion Mechanism
  10. Systemic Delivery of Anti-miRNA for Suppression of Triple Negative Breast Cancer Utilizing RNA Nanotechnology
  11. RNA as a stable polymer to build controllable and defined nanostructures for material and biomedical applications
  12. Discovery of a new method for potent drug development using power function of stoichiometry of homomeric biocomplexes or biological nanomotors
  13. Methods in Molecular Biology 1297: RNA Nanotechnology and Therapeutics: Methods and Protocols. Edited by Peixuan Guo and Farzin Haque
  14. RNA Nanoparticles Derived from Three-Way Junction of Phi29 Motor pRNA Are Resistant to I-125 and Cs-131 Radiation
  15. Construction of RNA–Quantum Dot Chimera for Nanoscale Resistive Biomemory Application
  16. Regression of Gastric Cancer by Systemic Injection of RNA Nanoparticles Carrying both Ligand and siRNA
  17. New approach to develop ultra-high inhibitory drug using the power function of the stoichiometry of the targeted nanomachine or biocomplex
  18. RNA nanoparticle as a vector for targeted siRNA delivery into glioblastoma mouse model
  19. Single pore translocation of folded, double-stranded, and tetra-stranded DNA through channel of bacteriophage phi29 DNA packaging motor
  20. Probing surface hydrophobicity of individual protein at single-molecule resolution using solid-state nanopores
  21. Delivery of RNA Nanoparticles into Colorectal Cancer Metastases Following Systemic Administration
  22. RNA Nanotechnology and Therapeutics
  23. Studies and application of Nanomotor for Single Pore Sensing, Single Fluorescence Imaging, and RNA Nanotechnology
  24. Overview of Methods in RNA Nanotechnology: Synthesis, Purification, and Characterization of RNA Nanoparticles
  25. Methods and Assays for Specific Targeting and Delivery of RNA Nanoparticles to Cancer Metastases
  26. Large Scale Purification of RNA Nanoparticles by Preparative Ultracentrifugation
  27. Simple Method for Constructing RNA Triangle, Square, Pentagon by Tuning Interior RNA 3WJ Angle from 60° to 90° or 108°
  28. Functional Assays for Specific Targeting and Delivery of RNA Nanoparticles to Brain Tumor
  29. Using RNA Nanoparticles with Thermostable Motifs and Fluorogenic Modules for Real-Time Detection of RNA Folding and Turnover In Prokaryotic and Eukaryotic Cells
  30. Binomial distribution for quantification of protein subunits in biological Nanoassemblies and functional nanomachines
  31. Physicochemically Tunable Polyfunctionalized RNA Square Architecture with Fluorogenic and Ribozymatic Properties
  32. Common mechanisms of DNA translocation motors in bacteria and viruses using one-way revolution mechanism without rotation
  33. RNA as a Boiling-Resistant Anionic Polymer Material To Build Robust Structures with Defined Shape and Stoichiometry
  34. Single molecule photobleaching (SMPB) technology for counting of RNA, DNA, protein and other molecules in nanoparticles and biological complexes by TIRF instrumentation
  35. Biophysical Studies Reveal New Evidence for One-Way Revolution Mechanism of Bacteriophage ϕ29 DNA Packaging Motor
  36. Entropy-Driven One-Step Formation of Phi29 pRNA 3WJ from Three RNA Fragments
  37. Stable RNA nanoparticles as potential new generation drugs for cancer therapy
  38. Two classes of nucleic acid translocation motors: rotation and revolution without rotation
  39. Finding of widespread viral and bacterial revolution dsDNA translocation motors distinct from rotation motors by channel chirality and size
  40. Ocular Delivery of pRNA Nanoparticles: Distribution and Clearance After Subconjunctival Injection
  41. Engineered Nanopore of Phi29 DNA-Packaging Motor for Real-Time Detection of Single Colon Cancer Specific Antibody in Serum
  42. Discovery of a new motion mechanism of biomotors similar to the earth revolving around the sun without rotation
  43. The ATPase of the phi29 DNA packaging motor is a member of the hexameric AAA+ superfamily
  44. Revolution rather than rotation of AAA+ hexameric phi29 nanomotor for viral dsDNA packaging without coiling
  45. Fabrication of pRNA nanoparticles to deliver therapeutic RNAs and bioactive compounds into tumor cells
  46. Ultrastable pRNA hexameric ring gearing hexameric phi29 DNA-packaging motor by revolving without rotating and coiling
  47. RNA Nanotechnology and Therapeutics
  48. Conference Scene: Advances in RNA nanotechnology promise to transform medicine
  49. Toward Reproducible Computational Research: An Empirical Analysis of Data and Code Policy Adoption by Journals
  50. RNA Junction Motifs as Scaffolds for Construction of Multifunctional RNA Nanoparticles
  51. Single-Molecule Approach to Study RNA Nanoparticles
  52. Design and Construction of RNA Nanoparticles Targeting Prostate Cancer
  53. Uniqueness, Advantages, Challenges, Solutions, and Perspectives in Therapeutics Applying RNA Nanotechnology
  54. Fabrication Methods for RNA Nanoparticle Assembly Based on Bacteriophage phi29 Packaging RNA Structural Features
  55. Thermodynamically Stable RNA Three-Way Junction for Constructing Multifunctional Nanoparticles for Delivery of Therapeutics
  56. Conjugation of RNA Aptamer to RNA Nanoparticles for Targeted Drug Delivery
  57. Mechanism of One-Way Traffic of Hexameric Phi29 DNA Packaging Motor with Four Electropositive Relaying Layers Facilitating Antiparallel Revolution
  58. Synthesis and Biological Evaluation of Novel Folic Acid Receptor-Targeted, β-Cyclodextrin-Based Drug Complexes for Cancer Treatment
  59. Tu1890 Targeting Colorectal Cancer Liver Metastases With Folate-Conjugated Ultrastable RNA Nanoparticles
  60. Channel Size Conversion of Phi29 DNA-Packaging Nanomotor for Discrimination of Single- and Double-Stranded Nucleic Acids
  61. Solid-state and biological nanopore for real-time sensing of single chemical and sequencing of DNA
  62. Incorporation of a viral DNA-packaging motor channel in lipid bilayers for real-time, single-molecule sensing of chemicals and double-stranded DNA
  63. Push Through One-Way Valve Mechanism of Viral DNA Packaging Nanomotor
  64. Rolling Circle Transcription of Tandem siRNA to Generate Spherulitic RNA Nanoparticles for Cell Entry
  65. Ultrastable synergistic tetravalent RNA nanoparticles for targeting to cancers
  66. Formation of lipid bilayers inside microfluidic channel array for monitoring membrane-embedded nanopores of phi29 DNA packaging nanomotor
  67. Real-Time Sensing and Discrimination of Single Chemicals Using the Channel of Phi29 DNA Packaging Nanomotor
  68. Role of Channel Lysines and the “Push Through a One-Way Valve” Mechanism of the Viral DNA Packaging Motor
  69. Synthesis, Conjugation, and Labeling of Multifunctional pRNA Nanoparticles for Specific Delivery of siRNA, Drugs, and Other Therapeutics to Target Cells
  70. “Push Through One-Way Valve” Mechanism of Viral DNA Packaging
  71. Three reversible and controllable discrete steps of channel gating of a viral DNA packaging motor
  72. Thermodynamically stable RNA three-way junction for constructing multifunctional nanoparticles for delivery of therapeutics
  73. RNA Nanotechnology: Methods for synthesis, conjugation, assembly and application of RNA nanoparticles
  74. Optimized method for the synthesis and purification of adenosine – Folic acid conjugates for use as transcription initiators in the preparation of modified RNA
  75. Assembly of multifunctional phi29 pRNA nanoparticles for specific delivery of siRNA and other therapeutics to targeted cells
  76. Dual functional RNA nanoparticles containing phi29 motor pRNA and anti-gp120 aptamer for cell-type specific delivery and HIV-1 Inhibition
  77. A Boost for the Emerging Field of RNA Nanotechnology
  78. Assembly of Therapeutic pRNA-siRNA Nanoparticles Using Bipartite Approach
  79. Pharmacological Characterization of Chemically Synthesized Monomeric phi29 pRNA Nanoparticles for Systemic Delivery
  80. Fabrication of Stable and RNase-Resistant RNA Nanoparticles Active in Gearing the Nanomotors for Viral DNA Packaging
  81. Membrane-Embedded Channel of Bacteriophage Phi29 DNA-Packaging Motor for Translocation and Sensing of Double-Stranded DNA
  82. Self-Assembly of Heptameric Nanoparticles Derived from Tag-Functionalized Phi29 Connectors
  83. Dual-Channel Single-Molecule Fluorescence Resonance Energy Transfer to Establish Distance Parameters for RNA Nanoparticles
  84. The emerging field of RNA nanotechnology
  85. Application of Phi29 Motor pRNA for Targeted Therapeutic Delivery of siRNA Silencing Metallothionein-IIA and Survivin in Ovarian Cancers
  86. One-Way Traffic of a Viral Motor Channel for Double-Stranded DNA Translocation
  87. Assembly Mechanism of the Sixty-Subunit Nanoparticles via Interaction of RNA with the Reengineered Protein Connector of phi29 DNA-Packaging Motor
  88. AIDS Treatment with Novel Anti-HIV Compounds Improved by Nanotechnology
  89. Engineering RNA for Targeted siRNA Delivery and Medical Application
  90. Design and application of single fluorophore dual-view imaging system containing both the objective- and prism-type TIRF
  91. Robust properties of membrane-embedded connector channel of bacterial virus phi29 DNA packaging motor
  92. Engineering of the Fluorescent-Energy-Conversion Arm of Phi29 DNA Packaging Motor for Single-Molecule Studies
  93. Construction of a laser combiner for dual fluorescent single molecule imaging of pRNA of phi29 DNA packaging motor
  94. Translocation of double-stranded DNA through membrane-adapted phi29 motor protein nanopores
  95. Targeted delivery of anti-coxsackievirus siRNAs using ligand-conjugated packaging RNAs
  96. Adjustable Ellipsoid Nanoparticles Assembled from Re-engineered Connectors of the Bacteriophage Phi29 DNA Packaging Motor
  97. Construction of Bacteriophage Phi29 DNA Packaging Motor and its Applications in Nanotechnology and Therapy
  98. Fabrication of polyvalent therapeutic RNA nanoparticles for specific delivery of siRNA, ribozyme and drugs to targeted cells for cancer therapy
  99. Approaches for stoichiometry and distance determination of nanometer bio-complex by dual-channel single molecule imaging
  100. Fabrication of Massive Sheets of Single Layer Patterned Arrays Using Lipid Directed Reengineered Phi29 Motor Dodecamer
  101. Evaluation of specific delivery of chimeric phi29 pRNA/siRNA nanoparticles to multiple tumor cells
  102. Reversible Switching of pRNA Activity on the DNA Packaging Motor of Bacteriophage phi29
  103. Bright-field analysis of phi29 DNA packaging motor using a magnetomechanical system
  104. Strand and nucleotide-dependent ATPase activity of gp16 of bacterial virus phi29 DNA packaging motor
  105. Capture and alignment of phi29 viral particles in sub-40 nanometer porous alumina membranes
  106. Modular assembly of chimeric phi29 packaging RNAs that support DNA packaging
  107. The effect of N- or C-terminal alterations of the connector of bacteriophage phi29 DNA packaging motor on procapsid assembly, pRNA binding, and DNA packaging
  108. From bench to bedside: successful translational nanomedicine
  109. Grouping of Ferritin and Gold Nanoparticles Conjugated to pRNA of the Phage phi29 DNA-Packaging Motor
  110. Crystallization of Phi29 Spindle-Shaped Nano-Bar Anti-Receptor with Glycosidase Domain
  111. Phi29 pRNA vector for efficient escort of hammerhead ribozyme targeting survivin in multiple cancer cells
  112. Viral nanomotors for packaging of dsDNA and dsRNA
  113. Counting of six pRNAs of phi29 DNA-packaging motor with customized single-molecule dual-view system
  114. Interaction of gp16 with pRNA and DNA for Genome Packaging by the Motor of Bacterial Virus phi29
  115. RNA Nanotechnology: Engineering, Assembly and Applications in Detection, Gene Delivery and Therapy
  116. A Special Issue on Bionanotechnology
  117. Specific Delivery of Therapeutic RNAs to Cancer Cells via the Dimerization Mechanism of phi29 Motor pRNA
  118. Controllable Self-Assembly of Nanoparticles for Specific Delivery of Multiple Therapeutic Molecules to Cancer Cells Using RNA Nanotechnology
  119. Translocation of Nicked but not Gapped DNA by the Packaging Motor of Bacteriophage phi29
  120. Quantum dots for robust and simple assays using single particles in nanodevices
  121. Construction and 3-D Computer Modeling of Connector Arrays with Tetragonal to Decagonal Transition Induced by pRNA of phi29 DNA-Packaging Motor
  122. Bottom-up Assembly of RNA Arrays and Superstructures as Potential Parts in Nanotechnology
  123. A simple mathematical formula for stoichiometry quantification of viral and nanobiological assemblage using slopes of log/log plot curves
  124. Gene cloning, purification, and stoichiometry quantification of phi29 anti-receptor gp12 with potential use as special ligand for gene delivery
  125. Use of acetone to attain highly active and soluble DNA packaging protein Gp16 of Phi29 for ATPase assay
  126. Construction of phi29 DNA-Packaging RNA Monomers, Dimers, and Trimers with Variable Sizes and Shapes as Potential Parts for Nanodevices
  127. Use of PEG to acquire highly soluble DNA-packaging enzyme gp16 of bacterial virus phi29 for stoichiometry quantification
  128. Only one pRNA hexamer but multiple copies of the DNA-packaging protein gp16 are needed for the motor to package bacterial virus phi29 genomic DNA
  129. Structure and function of φ29 hexameric RNA that drives the viral DNA packaging motor: Review
  130. Chemical Modification Patterns of Active and Inactive as Well as Procapsid-Bound and Unbound DNA-Packaging RNA of Bacterial Virus Phi29
  131. Probing the structure of monomers and dimers of the bacterial virus phi29 hexamer RNA complex by chemical modification
  132. Photoinduced cross-linking of RNA by cis-Rh(phen)2Cl2+ and cis-Rh(phen)(phi)Cl2+: A new family of light activatable nucleic acid cross-linking agents
  133. Sequence requirement for hand-in-hand interaction in formation of RNA dimers and hexamers to gear φ29 DNA translocation motor
  134. Inter-RNA Interaction of Phage φ29 pRNA to Form a Hexameric Complex for Viral DNA Transportation
  135. Inhibition of Phage φ29 Assembly by Antisense Oligonucleotides Targeting Viral pRNA Essential for DNA Packaging
  136. Circularly Permuted Viral pRNA Active and Specific in the Packaging of Bacteriophage φ29 DNA
  137. Differential diagnosis of infectious laryngotracheitis from other avian respiratory diseases by a simplified PCR procedure
  138. Construction of Recombinant Avian Infectious Laryngotracheitis Virus Expressing the β-Galactosidase Gene and DNA Sequencing of the Insertion Region
  139. A Highly Sensitive System for the in Vitro Assembly of Bacteriophage (ø29 of Bacillus subtilis
  140. The Proximate 5′ and 3′ Ends of the 120-Base Viral RNA (pRNA) Are Crucial for the Packaging of Bacteriophage Ø29 DNA
  141. Introduction: Principles, perspectives and potential applications in viral assembly
  142. Biological and biochemical properties of the small viral RNA(pRNA) essential for the packaging of the dsDNA of phage ø29
  143. Transactivation of the early SV40 promoter by avian infectious laryngotracheitis virus in avian hepatoma cells
  144. An avian hepatoma cell line for the cultivation of infectious laryngotracheitis virus and for the expression of foreign genes with a mammalian promotor
  145. sRNA of phage φ29 of Bacillus subtilis mediates DNA packaging of φ29 proheads assembled in Escherichia coli
  146. Regulation of the phage φ29 prohead shape and size by the portal vertex
  147. Characterization of the gene and an antigenic determinant of equine herpesvirus type-1 glycoprotein 14 with homology to gB-equivalent glycoproteins of other herpesviruses
  148. Prohead and DNA-gp3-dependent ATPase activity of the DNA packaging protein gp16 of bacteriophage φ29
  149. Initiation events in in-vitro packaging of bacteriophage φ29 DNA-gp3
  150. A small viral RNA is required for in vitro packaging of bacteriophage phi 29 DNA
  151. Characterization of the small RNA of the bacteriophage ø29 DNA packaging machine
  152. Bacterial Virus f29 DNA-Packaging Motor and Its Potential Applications in Gene Therapy and Nanotechnology